{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:05:12Z","timestamp":1790262312075,"version":"4.1.0"},"reference-count":22,"publisher":"Akademiai Kiado Zrt.","content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMICR"],"published-print":{"date-parts":[[2026,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Carbapenem-resistant\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    (CRKP) is a World Health Organization critical-priority pathogen, with a bloodstream-infection mortality of 40\u201370%. Ceftazidime-avibactam (CAZ-AVI) and colistin are key agents against CRKP, yet data on their minimum inhibitory concentrations (MICs) and association with carbapenemase genotypes in the Mekong Delta region of Vietnam are limited. This cross-sectional study on CRKP isolates from clinical specimens at hospitals in Can Tho City (November 2024\u2013July 2025) determined the MICs of CAZ-AVI and colistin and their association with carbapenemase genotypes (\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>KPC<\/jats:sub>\n                    ,\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA-48-like<\/jats:sub>\n                    ,\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>NDM<\/jats:sub>\n                    ,\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>IMP<\/jats:sub>\n                    ,\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>VIM<\/jats:sub>\n                    ). MICs were measured by broth microdilution and interpreted per CLSI M100 (2024) and EUCAST (2024, for colistin); carbapenemases were detected by the modified carbapenem inactivation method (mCIM), the D73C disc, and singleplex polymerase chain reaction (PCR). Among 112 strains, susceptibility was 42.0% for CAZ-AVI (MIC\n                    <jats:sub>50<\/jats:sub>\n                    \/MIC\n                    <jats:sub>90<\/jats:sub>\n                    &gt; 16\/4\u2009\u03bcg mL\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) and 82.1% for colistin (MIC\n                    <jats:sub>50<\/jats:sub>\n                    = 1\u2009\u03bcg mL\n                    <jats:sup>\u22121<\/jats:sup>\n                    , MIC\n                    <jats:sub>90<\/jats:sub>\n                    = 8\u2009\u03bcg mL\n                    <jats:sup>\u22121<\/jats:sup>\n                    ). Among 92 PCR-tested strains, co-carriage of \u22652 carbapenemase genes were most common, and\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA-48-like<\/jats:sub>\n                    was the most prevalent single gene. The CAZ-AVI MIC differed significantly among genotypes (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.002): isolates carrying\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>KPC<\/jats:sub>\n                    or\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA-48-like<\/jats:sub>\n                    retained the highest susceptibility, whereas all isolates carrying only a metallo-\u03b2-lactamase (\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>NDM<\/jats:sub>\n                    or\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>VIM<\/jats:sub>\n                    ) were resistant; the colistin MIC did not differ among genotypes (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.376). Carbapenemase genotyping should guide the use of CAZ-AVI in this setting, particularly for distinguishing serine carbapenemase producers from MBL producers, while the elevated colistin MIC90 supports continued surveillance of colistin susceptibility.\n                  <\/jats:p>","DOI":"10.1556\/030.2026.03111","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:22:55Z","timestamp":1790259775000},"update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["Distribution of ceftazidime-avibactam and colistin MIC values in carbapenem-resistant Klebsiella pneumoniae and its association with carbapenemase genotypes in Can Tho, Vietnam"],"prefix":"10.1556","author":[{"given":"Nguyen Thi","family":"Be Hai","sequence":"first","affiliation":[{"name":"University of Medicine and Pharmacy, Hue University, No. 06 Ngo Quyen Street, Hue City, Vietnam"},{"name":"Can Tho University of Medicine and Pharmacy, No. 179 Nguyen Van Cu Street, Can Tho City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Dinh","family":"Binh","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy, Hue University, No. 06 Ngo Quyen Street, Hue City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Hai Yen","sequence":"additional","affiliation":[{"name":"Can Tho University of Medicine and Pharmacy, No. 179 Nguyen Van Cu Street, Can Tho City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thanh","family":"Phong","sequence":"additional","affiliation":[{"name":"Hoan My Cuu Long Hospital, Lot 20 Vo Nguyen Giap Street, Can Tho City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong Phuoc","family":"Trung","sequence":"additional","affiliation":[{"name":"Can Tho University of Medicine and Pharmacy, No. 179 Nguyen Van Cu Street, Can Tho City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-2756","authenticated-orcid":true,"given":"Ngo Viet","family":"Quynh Tram","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy, Hue University, No. 06 Ngo Quyen Street, Hue City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"B1","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati H","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et\u00a0al. The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis 2025; 25: 1033\u201343. 10.1016\/S1473-3099(25)00118-5https:\/\/doi.org\/10.1016\/S1473-3099(25)00118-5"},{"key":"B2","series-title":"Syst Rev","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13643-025-02776-5","article-title":"Prevalence and molecular epidemiology of carbapenem resistance in Asia: a systematic review and meta-analysis","volume":"14","author":"Jayathilaka N","year":"2025","unstructured":"Jayathilaka N, Shehana S, Nakkawita D, Senaratne T. Prevalence and molecular epidemiology of carbapenem resistance in Asia: a systematic review and meta-analysis. Syst Rev 2025; 14: 123. 10.1186\/s13643-025-02776-5https:\/\/doi.org\/10.1186\/s13643-025-02776-5"},{"key":"B3","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1038\/s41598-026-36228-4","article-title":"Nationwide genomic surveillance of carbapenem- and colistin-resistant Klebsiella pneumoniae bloodstream isolates in Thailand (2020\u20132024)","volume":"16","author":"Krobanan K","year":"2026","unstructured":"Krobanan K, Kamjumphol W, Leethongdee P, Unahalekhaka A, Sripichai O, Cheunban N, et\u00a0al. Nationwide genomic surveillance of carbapenem- and colistin-resistant Klebsiella pneumoniae bloodstream isolates in Thailand (2020\u20132024). Sci Rep 2026; 16: 5853. 10.1038\/s41598-026-36228-4https:\/\/doi.org\/10.1038\/s41598-026-36228-4"},{"key":"B4","series-title":"J Hosp Infect","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jhin.2025.03.019","article-title":"Burden of carbapenem-resistant Gram-negative bacterial infections in Vietnam: a national hospital survey","volume":"165","author":"Larsson M","year":"2025","unstructured":"Larsson M, Truong LVN, Nguyen TD, Do TN, Hoang TBN, Nong MV, et\u00a0al. Burden of carbapenem-resistant Gram-negative bacterial infections in Vietnam: a national hospital survey. J Hosp Infect 2025; 165: 189\u201398. 10.1016\/j.jhin.2025.03.019https:\/\/doi.org\/10.1016\/j.jhin.2025.03.019"},{"key":"B5","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","volume":"79","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis 2024; 79: ciae403. 10.1093\/cid\/ciae403https:\/\/doi.org\/10.1093\/cid\/ciae403"},{"key":"B6","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann DE","year":"2012","unstructured":"Ehmann DE, Jahi\u0107 H, Ross PL, Gu RF, Hu J, Kern G, et\u00a0al. Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor. Proc Natl Acad Sci USA 2012; 109: 11663\u20138. 10.1073\/pnas.1205073109https:\/\/doi.org\/10.1073\/pnas.1205073109"},{"key":"B7","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/cmr.00064-16","article-title":"Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes","volume":"30","author":"Poirel L","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 2017; 30: 557\u201396. 10.1128\/cmr.00064-16https:\/\/doi.org\/10.1128\/cmr.00064-16"},{"key":"B8","series-title":"J Health Sci Med Res","doi-asserted-by":"publisher","DOI":"10.31584\/jhsmr.2023964","article-title":"The situation of antibiotic resistance in Klebsiella pneumoniae and carbapenemase-producing Klebsiella pneumoniae in Vietnam: a cross-sectional study","volume":"42","author":"Tran HD","year":"2024","unstructured":"Tran HD, Nguyen NC, Nguyen HD, Nguyen HTD, Nguyen TTT, Nguyen PH, et\u00a0al. The situation of antibiotic resistance in Klebsiella pneumoniae and carbapenemase-producing Klebsiella pneumoniae in Vietnam: a cross-sectional study. J Health Sci Med Res 2024; 42: e2023964. 10.31584\/jhsmr.2023964https:\/\/doi.org\/10.31584\/jhsmr.2023964"},{"key":"B9","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2024","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 34th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2024. CLSI Supplement M100. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/."},{"key":"B10","series-title":"Vietnam Med J","doi-asserted-by":"publisher","first-page":"252","DOI":"10.51298\/vmj.v534i1B.8292","article-title":"[Survey of ceftazidime\/avibactam susceptibility of Klebsiella pneumoniae in patients in the intensive care unit of Cho Ray Hospital]","volume":"534","author":"Nguyen NC","year":"2024","unstructured":"Nguyen NC, Vo NT, Tran TL, Le PMD, Truong TP. [Survey of ceftazidime\/avibactam susceptibility of Klebsiella pneumoniae in patients in the intensive care unit of Cho Ray Hospital]. Vietnam Med J 2024; 534: 252\u20136. Vietnamese. 10.51298\/vmj.v534i1B.8292https:\/\/doi.org\/10.51298\/vmj.v534i1B.8292"},{"key":"B11","series-title":"European committee on antimicrobial susceptibility testing: Breakpoint tables for interpretation of MICs and zone diameters","year":"2024","unstructured":"European committee on antimicrobial susceptibility testing: Breakpoint tables for interpretation of MICs and zone diameters, Version 14.0. EUCAST; 2024. https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"B12","series-title":"Mast group Ltd: AmpC detection discs, technical information. Bootle","year":"2018","unstructured":"Mast group Ltd: AmpC detection discs, technical information. Bootle. Mast Group Ltd; 2018. https:\/\/mastgrp.com\/."},{"key":"B13","series-title":"J Clin Microbiol","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1128\/jcm.02117-12","article-title":"Laboratory detection of Enterobacteriaceae that produce carbapenemases","volume":"50","author":"Doyle D","year":"2012","unstructured":"Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JDD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 2012; 50: 3877\u201380. 10.1128\/jcm.02117-12https:\/\/doi.org\/10.1128\/jcm.02117-12"},{"key":"B14","series-title":"Diagn Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel L","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70: 119\u201323. 10.1016\/j.diagmicrobio.2010.12.002https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002"},{"key":"B15","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1128\/aac.45.8.2224-2228.2001","article-title":"Metallo-\u03b2-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme","volume":"45","author":"Yan JJ","year":"2001","unstructured":"Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et\u00a0al. Metallo-\u03b2-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001; 45: 2224\u20138. 10.1128\/aac.45.8.2224-2228.2001https:\/\/doi.org\/10.1128\/aac.45.8.2224-2228.2001"},{"key":"B16","series-title":"Front Cell Infect Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.673503","article-title":"Molecular mechanisms of colistin resistance in Klebsiella pneumoniae in a tertiary care teaching hospital","volume":"11","author":"Liu Y","year":"2021","unstructured":"Liu Y, Lin Y, Wang Z, Hu N, Liu Q, Zhou W, et\u00a0al. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae in a tertiary care teaching hospital. Front Cell Infect Microbiol 2021; 11: 673503. 10.3389\/fcimb.2021.673503https:\/\/doi.org\/10.3389\/fcimb.2021.673503"},{"key":"B17","series-title":"Int J Biomed Eng Clin Sci","doi-asserted-by":"publisher","first-page":"73","DOI":"10.11648\/j.ijbecs.20251104.13","article-title":"Detection of carbapenemase genes in carbapenemase-producing Klebsiella pneumoniae isolated from Tay Nguyen Regional General Hospital, Vietnam","volume":"11","author":"Nie HN","year":"2025","unstructured":"Nie HN, Thuy LK, Loan NTK, Tuoi NH. Detection of carbapenemase genes in carbapenemase-producing Klebsiella pneumoniae isolated from Tay Nguyen Regional General Hospital, Vietnam. Int J Biomed Eng Clin Sci 2025; 11: 73\u20139. 10.11648\/j.ijbecs.20251104.13https:\/\/doi.org\/10.11648\/j.ijbecs.20251104.13"},{"key":"B18","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/antibiotics13111107","article-title":"The characterisation of carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae in a teaching hospital in Malaysia","volume":"13","author":"Lau MY","year":"2024","unstructured":"Lau MY, Ponnampalavanar S, Chong CW, Dwiyanto J, Lee YQ, Woon JJ, et\u00a0al. The characterisation of carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae in a teaching hospital in Malaysia. Antibiotics 2024; 13: 1107. 10.3390\/antibiotics13111107https:\/\/doi.org\/10.3390\/antibiotics13111107"},{"key":"B19","series-title":"Nat Commun","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","article-title":"International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe","volume":"15","author":"Budia-Silva M","year":"2024","unstructured":"Budia-Silva M, Kostyanev T, Ayala-Monta\u00f1o S, Bravo-Ferrer Acosta J, Garcia-Castillo M, Cant\u00f3n R, et\u00a0al. International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe. Nat Commun 2024; 15: 5092. 10.1038\/s41467-024-49349-zhttps:\/\/doi.org\/10.1038\/s41467-024-49349-z"},{"key":"B20","series-title":"Indian J Med Microbiol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/ijmm.IJMM_19_189","article-title":"Will ceftazidime\/avibactam plus aztreonam be effective for NDM and OXA-48-like producing organisms: lessons learnt from in vitro study","volume":"37","author":"Pragasam AK","year":"2019","unstructured":"Pragasam AK, Veeraraghavan B, Shankar BA, Bakthavatchalam YD, Mathuram A, George B, et\u00a0al. Will ceftazidime\/avibactam plus aztreonam be effective for NDM and OXA-48-like producing organisms: lessons learnt from in vitro study. Indian J Med Microbiol 2019; 37: 34\u201341. 10.4103\/ijmm.IJMM_19_189https:\/\/doi.org\/10.4103\/ijmm.IJMM_19_189"},{"key":"B21","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf240","article-title":"On the optimal treatment of metallo-\u03b2-lactamase-producing Enterobacterales infections using aztreonam and avibactam","volume":"81","author":"Carmeli Y","year":"2025","unstructured":"Carmeli Y, Cisneros JM, Paul M, Chow JW, Daikos GL. On the optimal treatment of metallo-\u03b2-lactamase-producing Enterobacterales infections using aztreonam and avibactam. Clin Infect Dis 2025; 81: e243. 10.1093\/cid\/ciaf240https:\/\/doi.org\/10.1093\/cid\/ciaf240"},{"key":"B22","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/jac\/dkx496","article-title":"Clinical outcomes after combination treatment with ceftazidime\/avibactam\u00a0and aztreonam for NDM-1\/OXA-48\/CTX-M-15-producing Klebsiella pneumoniae infection","volume":"73","author":"Shaw E","year":"2018","unstructured":"Shaw E, Rombauts A, Tubau F, Padull\u00e9s A, C\u00e0mara J, Lozano T, et\u00a0al. Clinical outcomes after combination treatment with ceftazidime\/avibactam\u00a0and aztreonam for NDM-1\/OXA-48\/CTX-M-15-producing Klebsiella pneumoniae infection. J Antimicrob Chemother\u00a02018; 73: 1104\u20136. 10.1093\/jac\/dkx496https:\/\/doi.org\/10.1093\/jac\/dkx496"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/030\/aop\/article-10.1556-030.2026.03111\/article-10.1556-030.2026.03111.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/030\/aop\/article-10.1556-030.2026.03111\/article-10.1556-030.2026.03111.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:22:56Z","timestamp":1790259776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/030\/aop\/article-10.1556-030.2026.03111\/article-10.1556-030.2026.03111.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1556\/030.2026.03111","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}